l e t t e r s
To identify susceptibility loci for ankylosing spondylitis, we undertook a genome-wide association study in 2,053 unrelated ankylosing spondylitis cases among people of European descent and 5,140 ethnically matched controls, with replication in an independent cohort of 898 ankylosing spondylitis cases and 1,518 controls. Cases were genotyped with Illumina HumHap370 genotyping chips. In addition to strong association with the major histocompatibility complex (MHC; P < 10 −800 ), we found association with SNPs in two gene deserts at 2p15 (rs10865331; combined P = 1.9 × 10 −19 ) and 21q22 (rs2242944; P = 8.3 × 10 −20 ), as well as in the genes ANTXR2 (rs4333130; P = 9.3 × 10 −8 ) and IL1R2 (rs2310173; P = 4.8 × 10 −7 ). We also replicated previously reported associations at IL23R (rs11209026; P = 9.1 × 10 −14 ) and ERAP1 (rs27434; P = 5.3 × 10 −12 ). This study reports four genetic loci associated with ankylosing spondylitis risk and identifies a major role for the interleukin (IL)-23 and IL-1 cytokine pathways in disease susceptibility.
Ankylosing spondylitis is a common cause of inflammatory arthritis, with a prevalence of ~5 per 1,000 in European populations 1 . It is charac terized by inflammation of the spine and sacroiliac joints causing pain and stiffness and ultimately new bone formation and progressive joint ankylosis. Hip and peripheral joint arthritis is common, and inflammation may also involve extraarticular sites such as the uveal tract, tendon insertions, proximal aorta and, rarely, the lungs and kidneys. The disease is strongly associated with the gene HLA-B27; how ever, only 1%-5% of HLAB27positive individuals develop ankylosing spondylitis, and there is increasing evidence to suggest that other genes must also be involved [2] [3] [4] [5] . Association has previously been confirmed between ankylosing spondylitis and SNPs in IL23R at chromosome 1p23 and ERAP1 (previously known as ARTS-1) at chromosome 5p15 (ref. 6) , and linkage has been demonstrated at genomewide significance to chromosome 6p (where HLAB is encoded) and chromosome 16q (lod score 4.7) 7 . We report here the first genome wide association study (GWAS) for ankylosing spondylitis.
To identify ankylosing spondylitis susceptibility genes, we performed a GWAS in a sample of ankylosing spondylitis cases among Australian, British and North American individuals of European descent (n = 2,053 in the final data set), using data from previously genotyped, ethnically matched British and North American individuals as controls (n = 5,140). Cases were genotyped with Illumina HumHap370 genotyping chips; 288,662 SNPs were available for study that were common to case and all control data sets after qualitycontrol filtering (see Online Methods). After data cleaning, a modest overall inflation of test statistics remained, with a genomic inflation factor (λ) of 1.06 (ref. 8) , excluding SNPs in the MHC (Supplementary Fig. 1 ). We then genotyped a total of 163 SNPs in a replication cohort of 898 British ankylosing spondylitis cases and 1,518 unselected British controls. The SNPs genotyped included 49 ancestryinformative SNPs and 114 SNPs in 105 chromo somal regions selected from the discovery sample on the basis of their strength of association in that sample and because of close proximity to genes of biologically plausible involvement in ankylosing spondylitis (Supplementary Table 1 ). Of the confirmation SNPs, 102 markers from 95 regions passed quality control filters and are reported here.
As expected, SNPs in the MHC on chromosome 6p were strongly associated with ankylosing spondylitis (rs7743761 P = 5.0 × 10 −304 ). Association was evident across a very broad region surrounding the MHC, including five SNPs lying in a 153kb region at 26.0-26.1 Mb from the ptelomere (5.4 Mb from HLAB), which achieved P < 10 −5 . The most associated SNP in this region was rs3734523 (P = 1.6 × 10 −6 ). However, conditional logistic regression analysis suggested that this was unlikely to represent a separate independent association because conditioning on five of the most significant SNPs from the MHC (rs7743761, rs2596501, rs3915971, rs2516509, rs1265112) caused the association to disappear (P = 0.27).
Excluding the MHC and surrounding regions, 25 SNPs from six independent loci were significantly associated with ankylosing spond ylitis, including the known ankylosing spondylitis-associated genes ERAP1 and IL23R, and two new loci, chromosomes 2p15 and 21q22 ( Table 1 and Supplementary Fig. 2 ). We also observed strong asso ciation within two more genes, ANTXR2 and IL1R2, with support in both the discovery and confirmation data sets.
Both nonMHC genes previously associated with ankylosing spondy litis, ERAP1 and IL23R, were significantly associated in this data set. The most strongly associated SNPs were rs30187 (P = 2.6 × 10 −11 ) and rs11209026 (P = 9.1 × 10 −14 ), confirming the strong association observed for these SNPs in the initial discovery set 6 .
We used SNP imputation to investigate association strength at untyped markers of the six nonMHC loci associated with ankylosing Genomewide association study of ankylosing spondylitis identifies nonMHC susceptibility loci
The Australo-Anglo-American Spondyloarthritis Consortium (TASC) 1 1 Complete lists of authors and affiliations appear at the end of this paper. l e t t e r s spondylitis. Considering IL23R, only marginally stronger association was observed with one imputed SNP (rs11465817, P = 1.2 × 10 −10 ) than with the strongest associated genotyped SNP, rs11209026 (P = 2.3 × 10 −9 ) (Fig. 1a) . IL23R has ten exons, with marker rs11209026 encoding a Q381R substitution in exon 9, and rs11465817 falling in intron 9, suggesting that this is the critical region involved in the association of IL23R with ankylosing spondylitis.
In ERAP1, the imputed data revealed a block of SNPs lying in a 4.6kb region between rs27529 (in exon 9) and rs469758 (in intron 12) achieving P < 10 −11 , more than 50 times more significant than any other imputed SNP (Fig. 1b) . In this region, only marker rs30187 is coding (R528K). It has previously been demonstrated that rs30187 causes a significant reduction in aminopeptidase activity toward a synthetic peptide substrate as well as alterations in substrate affinity 9 . Molecular modeling of the ERAP1 protein suggests that Arg528 lies at the mouth of the putative enzyme substrate pocket, perhaps explaining the lower aminopeptidase activity of this genetic variant. ERAP1 variants also correlate significantly with expression. Strong cisregulation of ERAP1 expression in lymphoblastoid cell lines was seen from SNPs close to and within ERAP1, including the marker rs30187 (C allele reduced expression, P = 0.00015) 10 . In our study, we saw no difference in ERAP1 expression in peripheral blood mononuclear cells (PBMCs) from ankylosing spondylitis cases compared with controls (Supplementary Table 2 ), suggesting that this is a less likely explanation of the mecha nism of association of ERAP1 with ankylosing spondylitis.
Three SNPs at the 2p15 locus achieved genomewide significance in the discovery set: rs10865331 (P = 6.1 × 10 −15 ), rs10865332 (P = 3.5 × 10 −10 ) and rs4672503 (P = 9.3 × 10 −10 ). No imputed SNP was more significantly associated than rs10865331. In the rep lication study we genotyped two SNPs in this locus, both of them confirming the discovery set findings: rs4672495 (P = 8.4 × 10 −4 ) and rs10865331 (P = 5.5 × 10 −6 ). The combined level of association of these SNPs was highly significant: rs4672495 (P = 3.2 × 10 −9 ) and rs10865331 (P = 1.9 × 10 −19 ). Combining the imputed and genotyped data, there is a block of SNPs lying between marker rs10865331 and rs4672507 in tight linkage disequilibrium (LD) (r 2 > 0.8) with >1,000 times stronger significance than any other SNP at this locus, encompassing a 23kb region likely to contain the causative variant(s) responsible for the association observed (Fig. 1c) . No genes are encoded within this region, the nearest gene to the most strongly associated marker rs10865331 being 100 kb distant (B3GNT2). We are not aware of this region being associated previously with any known disease. B3GNT2 encodes UDPGlcNAc: betaGal beta1,3Nacetylglucosaminyltransferase 2, a protein not as yet known to have any immunological function.
At chromosome 21q22, three SNPs across an 11kb region achieved genomewide significance in the discovery cohort: rs2242944 (P = 2.7 × 10 −14 ), rs2836878 (P = 4.9 × 10 −12 ) and rs378108 (P = 6.1 × 10 −11 ) (Fig. 1d) . SNP rs2242944 also showed strong association in the confirmation cohort (P = 5.6 × 10 −7 ) and in the combined analysis (P = 8.3 × 10 −20 ). The nearest gene to the most strongly associated SNP, rs2242944, is 82 kb distant (PSMG1, proteasome assembly chaperone 1). This region has recently been associated with pediatriconset inflammatory bowel disease (IBD), in which the most strongly asso ciated SNP was rs2836878; positive association was seen with over representation of the minor allele, as was the case in our ankylosing spondylitis data set (P = 4.1 × 10 −10 ). This SNP is in strong LD with the strongest ankylosing spondylitis-associated marker, rs2242944 (r 2 = 0.6, D = 1) 11 . Increased expression of PSMG1 was observed in colonic biopsies from IBD cases, and it was suggested that this may be the gene involved at this locus. Ankylosing spondylitis and IBD are closely related conditions, with ~70% of those with ankylosing spondylitis having microscopic terminal ileitis resembling Crohn's disease 12 and ~10% of those with IBD having ankylosing spondylitis. Crohn's disease and ankylosing spondylitis are each associated with IL23R SNPs, and it is likely that further shared genetic susceptibility factors exist. We saw strong association even among those cases with no clinical IBD (n = 1,159 cases, rs2242944, P = 1.3 × 10 −9 ), indicating that the association was present even in cases of primary ankylosing spondylitis in the absence of clinically manifest IBD. l e t t e r s PSMG1 was not differentially expressed in PBMCs from cases with active ankylosing spondylitis compared with healthy controls (Supplementary Fig. 3 ), nor in relationship to ankylosing spondylitisassociated chromosome 21q22 SNPs. A large recombination hotspot lying between PSMG1 and the ankylosing spondylitis-associated SNPs makes it unlikely that the association signal observed is due to effects from SNPs located in or close to PSMG1. We feel that its remoteness to the associated locus, absence of differential expression with disease, and lack of evidence of a relevant biological function make it an unlikely candidate to be directly involved in ankylosing spondylitis susceptibility. Rather, we hypothesize that the chromo some 2p15 and 21q22 regions harbor either noncoding RNA species or hitherto unreported proteincoding genes that are likely to be involved in susceptibility to ankylosing spondylitis. To investigate this further, we performed a transcriptomewide profiling study of expressed sequence tags and small RNAs derived from PBMCs from four active ankylosing spondylitis cases and three healthy controls using Illumina's deep sequencing approach. No small regulatory RNAs such as microRNAs were seen within the regions of highly associated SNPs at either locus, although, consistent with recent findings 13 , these were identified in association with transcription start sites of flanking genes outside the diseaseassociated region ( Supplementary Fig. 4) . At both loci, we identified sequence tags derived from long RNAs. These either represent long mRNAlike noncoding RNA species or, alternatively, previously undescribed mRNA isoforms originating from distal promoters of adjacent proteincoding genes.
Fourteen SNPs in a 61kb region encompassing IL1R2 achieved nominal significance, with the strongest association observed with genotyped markers at rs2310173 (P = 8.3 × 10 −6 ) and with imputed markers at rs10185424 (P = 5.4 × 10 −6 ) (Supplementary Fig. 3a) . Marker rs2310173 was also associated with ankylosing spondylitis volume 42 | number 2 | february 2010 Nature GeNetics l e t t e r s in the replication study (P = 0.018) and showed a high level of significance in the combined analysis (P = 4.8 × 10 −7 ). IL1R2 is cleaved from cell membranes, possibly by ERAP1 (ref. 14) and acts as a decoy receptor, interfering with the binding of IL1 to IL1RI. One possible explanation for the associations of ERAP1 and IL1R2 with ankylosing spondylitis is that the diseaseassociated genetic vari ants affect cleavage of IL1R2 from the cell surface. In this respect, we note that several SNPs in TNFRSF1A achieved moderate levels of association in the discovery set (strongest associated SNP, rs1800693, P = 6.9 × 10 −5 ). TNFRSF1A encodes tumor necrosis factor receptor 1, which may also be cleaved from the cell surface by ERAP1 (ref. 15) .
No support for this association was seen in our replication study, but SNPs in TNFRSF1A have been associated with both ulcerative colitis and Crohn's disease previously 16, 17 , providing some support for this association with ankylosing spondylitis. Tumor necrosis factor overexpression in mice leads to inflammatory bowel disease and to sacroiliitis resembling ankylosing spondylitis, and is dependent on expression of TNFRSF1A (ref. 18) . ANTXR2, recessive mutations of which cause juvenile hya line fibromatosis (MIM228600) and infantile systemic hyalinosis (MIM236490), encodes capillary morphogenesis protein2 (CMP2). The SNP rs4333130 was associated with ankylosing spondylitis in both the discovery cohort (P = 7.5 × 10 −7 ) and replication cohort (P = 0.029) as well as overall (P = 9.3 × 10 −8 ). In the imputed data set, no markers were more strongly associated ( Supplementary  Fig. 3b) . A functional explanation for this association with ankylosing spondylitis is not clear.
The power of this study to detect small to moderate genetic effects was modest. We calculate that the discovery phase of the study has 2%-21% power to identify SNPs conferring an additive allelic odds ratio of 1.2 with minor allele frequencies of 0.1-0.5 at α = 5 × 10 −7 , assuming D′ = 0.9 and the marker and diseaseassociated allele frequencies are equal. Further GWAS with larger sample sizes will therefore be useful and likely to identify more genes associated with ankylosing spondylitis. The identification of four genetic loci newly associated with ankylosing spondylitis extends our understanding of the genetic etiology of this disorder and provides an important foun dation for future hypothesisdriven research into the pathogenesis of this common and debilitating condition.
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